CMAX Technologies Information

View Top Employees from CMAX Technologies

The Company was established in 2008 with an objective to provide prompt and reliable services to the Pharmaceutical sector worldwide and to improve the product quality through technological innovations . The company is capable of handling Formulation and Analytical Research of Solid Orals dosage forms (tablets, capsules etc.). Our proprietary technologies are well established in developing once-a-day dosage form of drugs such as Quetiapine Fumarate,and Nifedipine. The Company has a strong formulation and analytical expertise in sustained release delivery systems. The Company is equipped with a pilot galenic research and development facility located in Toronto, Canada. CMAX is actively seeking partnership arrangements for the development and commercialization of products currently in its pipeline and for new products using CMAX's proprietary delivery systems. CMAX also provides customized solutions for pharmaceutical companies interested in having a turn-key development program that can be transferred directly to a large scale production facility. Home || Licencing Opportunities || Services || Facilities || Picture Gallary || Contact Us

Website	http://www.cmaxtechnologies.net
Revenue	$3 million
Employees	View employees
Address	223 Riviera Dr, Markham, Ontario L3R 5J6, CA
Phone	+1 905-475-2188
Industry	Pharmaceuticals, Healthcare
Competitors	Deloitte, IBM, Accenture, Wipro, Tata Consultancy Services, Capgemini, Infosys, Tech Mahindra, HCLTech, Cognizant Softvision +51 more (view full list)
SIC	SIC Code 28 Companies, SIC Code 283 Companies
NAICS	NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies